A molecular linkage analysis in 11 families with X-linked agammaglobulinemia (XLA) localized the XLA gene to the proximal part of the long arm of the human X chromosome. Significant linkage was detected between XLA and loci defined by two polymorphic DNA probes called 19-2 for the DXS3 locus and S21 for the DXS17 locus. Both localize to the region Xq2l.3-Xq22. Most likely recombination distances (0) and associated logarithm of the odds (lod) scores for the XLA-DXS3 and XLA-DXS17 pairs were d = 0.04 morgans (lod, 3.65) and 0 = 0 (lod, 2.17), respectively. Tight linkage between XLA and the locus DXS43 defined by the X short arm probe D2 (localized to Xp22-Xp21) was strongly excluded and we obtained no evidence for significant linkage between XLA and any other X short arm probe. The probe pair 19-2 and S21 should be informative for molecular linkage-based analysis of XLA segregation in the majority of families afflicted with this disorder.
Introduction
In one form of agammaglobulinemia, which is inherited in an X-linked recessive mode (XLA),' the serum of males expressing the disease contains markedly diminished or undetectable quantities of all immunoglobulins (1) , and B lymphocytes are markedly decreased or absent in peripheral blood, bone marrow, and lymphoid tissues from affected patients. Mature plasma cells cannot be found, although the bone marrow contains normal numbers of pre-B lymphocytes, a fact that might ultimately lead both to basic understanding of the pathogenesis of this disorder and to specific therapy (2) . At present, one is limited to empirical therapeutic action, which consists of prophylaxis against recurrent pyogenic infections, achieved by the regular administration of pooled human immune serum globulin. 1 . Abbreviations used in this paper: lod, logarithm ofthe odds of linkage; RFLPs, restriction fragment-length polymorphisms; XLA, X-linked agammaglobulinemia.
Diagnosis of XLA is restricted at present to males who are well past the newborn period. Female heterozygotes for this disease (1) cannot be detected directly, although obligate heterozygotes can be identified by pedigree analysis. Heterozygous females are immunologically normal. It has not yet been possible to perform prenatal diagnosis of XLA in male fetuses. Affected newborn males with XLA are passively protected against infection by maternal IgG for the first year of life (1) . Moreover, the clinical and immunologic abnormalities in affected males vary both within and between families, the latter feature promoting the suspicion that "X-linked agammaglobulinemia" might not be a single defect at a unique locus (3) . Mapping XLA on the X chromosome, before establishing its linkage relationships with other X chromosome loci, about which published data do not yet exist, would help address this question of XLA heterogeneity and lead to more definitive diagnosis of the disorder.
We undertook this study to ascertain if loci defined by restriction fragment-length polymorphisms (RFLPs) (4) could be found sufficiently close to the XLA locus in available families to provide information on chromosome map location and perhaps to be of use in prenatal diagnosis. Toward this purpose, segregation analysis in 13 families at risk for the transmission of XLA was performed. In view of the rarity of this disorder and the difficulty in finding kindred suitable for this type of analysis, it was fortuitous that we were able to determine that two cloned DNA fragments from the human X chromosome (named S21 [5] and 19-2 [6, 7] Gel analysis and filter hybridization. Genomic DNA was digested for several hours in the appropriate buffer with various restriction enzymes. Electrophoresis was carried out in 0.8% agarose gels in Tris borate buffer (90 mM Tris, 90 mM boric acid, 25 mM EDTA). The gel was denatured in 0.5 M NaOH, 0.5 M NaCi, and neutralized in 0.5 M Tris, pH 7.6, 0.6 M NaCl. DNA from the gel was transferred to nitrocellulose in 20X SSC (3 M NaCl, 0.3 M Na citrate) using the method of Southern (14) . After transfer, the filters were rinsed in 4X SSC, and baked for 2 h at 80'C. Prehybridization was performed in a mixture containing 50% formamide, 4X SSC, 8% dextran sulfate, lOx Denhardt's solution (15), 25 gg/ml denatured salmon DNA, 100 jsg/ml transfer RNA (tRNA), 1 (28, 29) . One of these females had decreased T helper lymphocytes but normal numbers ofB cells. They concluded that an immunoregulatory defect was present but that the defect did not resemble XLA. Schuurman (30) has studied a number offamilies with XLA with two short-arm DNA probes, RC8 and L128. He concluded that the XLA gene must lie between Xp2 1 and Xpl 1, although the maximum calculated lod scores published for these probes did not reach 1.0. As stated earlier, we have been unable to find any linkage between the X short-arm marker locus DXS43 defined by probe D2 and the XLA gene, and none of the fragmentary data on other X shortarm marker loci and XLA in our families are indicative of an Xp location for XLA. Other abnormalities and deletions of the short arm of X chromosome in males have been described, and none of these patients were reported to have XLA (31, 32) .
From our studies it appears that the XLA in the families we examined is a single locus defect, despite the clinical variability among the cases. Now that the XLA gene has been mapped to the proximal region of the long arm of the X chromosome, it appears useful to apply additional RFLPs to refine the map location and ultimately, to use the information obtained for prenatal diagnosis of XLA. For probes 19-2 and S21 described in this study, greater than three-quarters of XLA heterozygotes might be amenable to such an analysis.
